Inventor · disambiguated record
Danielle Van Manen
Also filed as: VAN MANEN DANIELLE
6 granted patents·2 pending applications·12 citations·filing 2015–2021
77Inventor score
Top patents by PatentIndex Score
8 records- 0185US10369214B2Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·5 cites·51 claims
- 0284US10137191B2Methods and compositions for inducing protective immunity against human immunodeficiency virus infectionBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Granted Nov 27, 2018·5 cites·14 claims
- 0381US11207400B2Compositions and methods for inducing protective immunity against human immunodeficiency virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Dec 28, 2021·1 cites·20 claims
- 0474US10471137B2Methods for inducing protective immunity against human immunodeficiency virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Nov 12, 2019·1 cites·27 claims
- 0573US2022096622A1Compositions and Methods for Inducing Protective Immunity Against Human Immunodeficiency Virus InfectionJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 0671US11896663B2Immunodeficiency virus type 1 (HIV-1) mutant envelope proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 13, 2024·0 cites·6 claims
- 0770US10973907B2Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigensJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Apr 13, 2021·0 cites·15 claims
- 0847US2019022212A1Methods for safe induction of cross-clade immunity against human immunodeficiency virus infection in humanBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →